col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

53 Results       Page 1

Oceanside Publications: Allergy and Asthma Proceedings
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―07 Assessing severity of COVID-19 and the development of multi system inflammatory syndrome in children (MIS-C) in pediatric patients with atopic disease Natalie E. Rudsenske, Jessica B. Perkins
2 [GO] 2023―Dec―28 An 82-year-old man with new skin lesions after COVID-19 vaccination Patricia J. Choi, Merritt L. Fajt
3 [GO] 2023―Nov―03 Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients Helene Karcher, Matthias Schoenberger, Tejaswini Rayban, Caoimhe Kelly, Andrew Heaney, Alexander Mackay
4 [GO] 2023―Sep―06 The COVID-19 impact on severe uncontrolled asthma costs and biologic use Najm S. Khan, Elizabeth Rubin, Bernard McKenna, Bernard L. Palowitch, Frank Sonnenberg, Judith Argon, Reynold A. Panettieri
5 [GO] 2023―Sep―06 Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS Maria D. LaRusso, Cesar E. Abadia
6 [GO] 2023―Sep―06 Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic Jennifer Brennan, Kelsey Yamada, Taha Al-Shaikhly, Gisoo Ghaffari
7 [GO] 2023―Jul―22 Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease Melek Cihanbeylerden, Ozge Can Bostan, Gulseren Tuncay, Cagla Safak, Ebru Damadoglu, Gul Karakaya, Ali Fuat Kalyoncu
8 [GO] 2023―May―27 The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist Lawrence D. Frenkel, Sananda Gaur, Joseph A. Bellanti
9 [GO] 2023―Mar―06 Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being Sandra C. Christiansen, Camila Lopes Veronez, Tukisa D. Smith, Marc A. Riedl, Bruce L. Zuraw
10 [GO] 2022―Dec―28 Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
11 [GO] 2022―Nov―06 Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course Nida Oztop, Semra Demir, Ilkim Deniz Toprak, Derya Unal, Aslı Gelincik
12 [GO] 2022―Nov―06 Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination Mechelle Miller, Michael Tracey, Meagan Simpson, Cecilia Mikita
13 [GO] 2022―Sep―06 Asthma biomarkers and COVID-19 continue to dominate current medical issues Joseph A. Bellanti, Russell A. Settipane
14 [GO] 2022―Sep―06 Cat allergy in children and the effect of the COVID-19 pandemic Sule Buyuk Yaytokgil, Azize Pinar Metbulut, Tayfur Giniş, Muge Toyran, Ersoy Civelek, Emine Dibek Misirlioğlu
15 [GO] 2022―Sep―06 Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns Timothy Kaddis, Shyam Joshi, Karen M. Anstey
16 [GO] 2022―Sep―06 Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines Dongmei Li, Richard Calderone, Talal M. Nsouli, Elizabeth Reznikov, Joseph A. Bellanti
17 [GO] 2022―Sep―06 The long COVID syndrome: A conundrum for the allergist/immunologist Joseph A. Bellanti
18 [GO] 2022―May―07 COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results Don A. Bukstein, Jacqueline Eghrari-Sabet, Mary Hart, Tanisha Hill, Purvi Parikh, Tonya A. Winders
19 [GO] 2022―May―07 Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome Danilo Buonsenso, Michele Piazza, Attilio L. Boner, Joseph A. Bellanti
20 [GO] 2022―Mar―23 Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19 Can Tuzer, Pelin Karadag, Ozan Yegit, Deniz Eyice, Nida Oztop, Ali Can, et al. (+7)
21 [GO] 2022―Jan―05 Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose Megan C. Gallagher, Sarah Haessler, Elizabeth Pecoy-Whitcomb, Jonathan Bayuk
22 [GO] 2022―Jan―05 Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management Vesna Grivcheva-Panovska, Timothy J. Craig, Hilary Longhurst, Noémi Bara, Irina Panovska
23 [GO] 2022―Jan―05 Delayed systemic urticarial reactions following mRNA COVID-19 vaccination Mitchell M. Pitlick, Avni Y. Joshi, Alexei Gonzalez-Estrada, Sergio E. Chiarella
24 [GO] 2022―Jan―05 Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2 Eli Magen, Avi Yakov, Ilan Green, Ariel Israel, Shlomo Vinker, Eugene Merzon
25 [GO] 2021―Dec―06 COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications Camila Lopes Veronez, Sandra C. Christiansen, Tukisa D. Smith, Marc A. Riedl, Bruce L. Zuraw
26 [GO] 2021―Dec―06 Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection? Emine Vezir, Mina Hizal, Burcu Cura Yayla, Kubra Aykac, Arzu Yilmaz, Gamze Kaya, et al. (+3)
27 [GO] 2021―Dec―06 COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol Gayatri B. Patel, Krishan D. Chhiba, Michael M. Chen, Amina Guo, Melissa M. Watts, Jane Cullen, et al. (+7)
28 [GO] 2021―Dec―06 The immunologic response to severe acute respiratory syndrome coronavirus 2 Nicole K. Le, Kelsey Kaman, Hannah C. Martin, Jyotsna Mullur, Kristen K. Stenehjem, Lokesh Coomar, et al. (+4)
29 [GO] 2021―Dec―06 SARS-CoV-2 infection and the human immune system: A continuing journey of discovery Joseph A. Bellanti, Russell A. Settipane
30 [GO] 2021―Sep―06 Effect of COVID-19 on hereditary angioedema activity and quality of life Ozge Can Bostan, Gulseren Tuncay, Ebru Damadoglu, Gul Karakaya, Ali Fuat Kalyoncu
31 [GO] 2021―Sep―06 Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic Samantha Arsenault, Jacob Hoofman, Pavadee Poowuttikul, Elizabeth Secord
32 [GO] 2021―Sep―06 The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better? Lawrence D. Frenkel
33 [GO] 2021―Sep―06 Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist Joseph A. Bellanti, Russell A. Settipane
34 [GO] 2021―Aug―10 COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance Joseph A. Bellanti
35 [GO] 2021―Jun―30 Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis Andrea N. Sitek, Justine M. Ade, Sergio E. Chiarella, Rohit D. Divekar, Mitchell M. Pitlick, Vivek N. Iyer, et al. (+2)
36 [GO] 2021―Jun―30 Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria Sengul Beyaz, Semra Demir, Nida Oztop, Pelin Karadag, Raif Coskun, Bahauddin Colakoglu, et al. (+2)
37 [GO] 2021―Jun―30 COVID-19: A continuing challenge for the allergist/immunologist Joseph A. Bellanti, Russell A. Settipane
38 [GO] 2021―May―25 Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies Tonya Winders, Lawrence DuBuske, Don A. Bukstein, Eli O. Meltzer, Dana Wallace, Karen Rance
39 [GO] 2021―May―13 COVID-19 in Italian children and adolescents: The role of allergy and asthma Maria Angela Tosca, Amelia Licari, Gian Luigi Marseglia, Giorgio Ciprandi
40 [GO] 2021―May―13 Is nutraceutical supplementation appropriate for COVID-19 management? Michele Piazza, Attilio L. Boner, Sandro Girotto, Ercole Concia, Joseph A. Bellanti
41 [GO] 2021―May―13 Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction Désirée E. Larenas-Linnemann, José A. Ortega-Martell, María V. Blandón-Vijil, Noel Rodríguez-Pérez, Jorge A. Luna-Pech, Alan Estrada-Cardona, et al. (+8)
42 [GO] 2021―Feb―04 COVID-19 in a patient with severe asthma using mepolizumab Kurtulus Aksu, Selma Yesilkaya, Musa Topel, Suleyman Turkyilmaz, Dilek Cuhadar Ercelebi, Ali Oncul, et al. (+2)
43 [GO] 2021―Jan―06 COVID-19 in children: Pathogenesis and current status Lawrence D. Frenkel, Fernando Gomez, Joseph A. Bellanti
44 [GO] 2021―Jan―06 The challenge of COVID-19 that permeates the practice of allergy/immunology Joseph A. Bellanti, Russell A. Settipane
45 [GO] 2021―Jan―06 For the patient: COVID-19 vaccines and the public challenges and solutions
46 [GO] 2020―Dec―24 Considerations for asthma management and viral transmission in the era of COVID-19 Mitchell M. Pitlick, Avni Y. Joshi
47 [GO] 2020―Dec―24 The war on infectious diseases: COVID-19 vaccines and the public: Challenges and solutions Joseph A. Bellanti, Russell A. Settipane
48 [GO] 2020―Nov―04 COVID-19 in children: Pathogenesis and current status Lawrence Frenkel, Fernando Gomez, Joseph A Bellanti
49 [GO] 2020―Oct―28 The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond Joseph A. Bellanti, Russell A. Settipane
50 [GO] 2020―Oct―28 Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 Stefano Perlini, Giorgio Ciprandi, Riccardo Castagnoli, Amelia Licari, Gian Luigi Marseglia
51 [GO] 2020―Aug―15 The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation Joseph A Bellanti
52 [GO] 2020―Jul―01 COVID-19, allergic disease and asthma: Extraordinary challenges for the allergist/immunologist Joseph A. Bellanti, Russell A. Settipane
53 [GO] 2020―Jul―01 Successful treatment of coronavirus disease 2019 in a patient with asthma Avni Y. Joshi, Roshini M. Mullakary, Vivek N. Iyer

53 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec